Diagnosis | Number of patients (%) | Number of patients with FN episodes (%) | Mean number of episodes per patient | Range of number of episodes per patient |
---|---|---|---|---|
Osteogenic sarcoma | 8 (3%) | 7 (87%) | 3.13 | 0–7 |
Ewings sarcoma | 5 (2%) | 4 (80%) | 2.20 | 0–5 |
Rhabdomyosarcoma | 15 (5%) | 11 (79%) | 1.93 | 0–6 |
Hepatoblastoma | 9 (3%) | 5 (56%) | 1.22 | 0–5 |
Acute myeloid leukemia (AML) | 16 (6%) | 7 (44%) | 1.00 | 0–5 |
Neuroblastoma | 23 (8%) | 11 (48%) | 0.83 | 0–5 |
Non-Hodgkin's lymphoma | 24 (9%) | 14 (58%) | 0.75 | 0–4 |
Acute lymphoblastic leukemia (ALL) | 85 (31%) | 41 (48%) | 0.73 | 0–7 |
Others * | 22 (8%) | 9 (41%) | 0.41 | 0–3 |
Hodgkin's lymphoma | 25 (9%) | 8 (32%) | 0.36 | 0–5 |
Central nervous system tumors | 26 (9%) | 7 (27%) | 0.23 | 0–3 |
Wilms tumor | 17 (6%) | 3 (18%) | 0.12 | 0–1 |
Total | 275 | 127 (46%) |